{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0000", "char_start": 0, "char_end": 2000, "pages": [1], "text": "July 2019\nVolume 35 | Number 8\nMedicaid Pharmacy Prior Authorization Programs Update\nOn May 16, 2019, the New York State Medicaid Drug Utilization Review (DUR) Board recommended changes\nto the Medicaid pharmacy prior authorization (PA) programs. The Commissioner of Health has reviewed the\nrecommendations of the Board and has approved changes to the Preferred Drug Program (PDP) within the fee-\nfor-service (FFS) pharmacy program.\nEffective July 25, 2019, PA requirements will change for some drugs in the following PDP classes and new\nclasses have been added to the Preferred Drug List (PDL):\n• Anticonvulsants – Other\n• Central Nervous System (CNS) Stimulants\n• Multiple Sclerosis Agents\n• Growth Hormones\n• Erythropoiesis Stimulating Agents\n• Antihyperuricemics (includes the Xanthine Oxidase Inhibitors)\n• Anticholinergics/Chronic Obstructive Pulmonary Disease (COPD) Agents\nIn addition, the following new therapeutic classes will be added to PDL:\n• Antimigraine Agents – Other\n• Movement Disorder Agents\n• Colony Stimulating Factors\n• Immunosuppressives – Oral\nFor more detailed information on the above DUR Board recommendations, please refer to the meeting summary\nat: https://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2019/.\nA full listing of drugs subject to PDP, Clinical Drug Review Program (CDRP), DUR Program, Brand Less Than\nGeneric program (BLTG), Dose Optimization Program and the Mandatory Generic Drug Program (MGDP) can\nbe found at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf. This document includes the\nmost up-to-date information on the Medicaid FFS Pharmacy PA programs.\nTo obtain a PA, please call the Medicaid Pharmacy Prior Authorization Clinical Call Center at 1-877-309-9493.\nThe call center is available 24 hours per day, 7 days per week and is staffed with pharmacy technicians and\npharmacists who will assist providers and provider agents in obtaining a PA. Medicaid-enrolled prescriber with\nan active e-PACES (Electronic Provider A", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0001", "char_start": 1750, "char_end": 3750, "pages": [1, 2], "text": "center is available 24 hours per day, 7 days per week and is staffed with pharmacy technicians and\npharmacists who will assist providers and provider agents in obtaining a PA. Medicaid-enrolled prescriber with\nan active e-PACES (Electronic Provider Assisted Claim Entry System) account can initiate PA requests through\nthe web-based application PAXpress®. The website for PAXpress is https://paxpress.nypa.hidinc.com/. The\nwebsite may also be accessed through the eMedNY website at http://www.eMedNY.org as well as Magellan\nMedicaid Administration's website at http://newyork.fhsc.com.\n\nAndrew M. Cuomo\nGovernor\nState of New York\nHoward A. Zucker, M.D., J.D.\nCommissioner\nNew York State\nDepartment of Health\nDonna Frescatore\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nMedicaid Pharmacy Prior Authorization Programs Update ............................................................................................ Cover\nPharmacy\nReminder: Pharmacy Delivery Policy ...................................................................................................................................... 3\nPolicy and Billing\nNew York State Medicaid Coverage of CYP2C9 Testing for Siponimod Prescribing ............................................................. 4\nNew York State Medicaid Coverage of Duchenne Muscular Dystrophy (DMD) Testing for Exondys 51® Prescribing .......... 4\nNew York State Medicaid Expansion of Prognostic Tests for Breast Cancer Treatment ...................................................... 5\nBilling Guidance for Reporting Alternate Level of Care .......................................................................................................... 6\nUpdate: Credentialed Alcoholism and Substance Abuse Counselor (CASAC) Now Approved for Billing Within an\nArticle 28 Setting for DSRIP Project 3.a.i and Integrated Outpatient Services ..................", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0002", "char_start": 3500, "char_end": 5500, "pages": [2, 3], "text": ".............................................. 6\nUpdate: Credentialed Alcoholism and Substance Abuse Counselor (CASAC) Now Approved for Billing Within an\nArticle 28 Setting for DSRIP Project 3.a.i and Integrated Outpatient Services ....................................................................... 6\nBilling Guidance for Reporting Newborn Birth Weights .......................................................................................................... 7\nBilling Guidance for Reporting Mechanical Ventilation .......................................................................................................... 7\nAll Providers\nReminder to Sign-up for Electronic Funds Transfer (EFT) and Electronic Remittance Advice (ERA) or Portable\nDocument Format (PDF) Remittances .................................................................................................................................... 8\nReminder: Subscribe to the eMedNY LISTSERV® ................................................................................................................. 8\nProvider Training Schedule and Registration ......................................................................................................................... 9\nNew York Medicaid EHR Incentive Program ........................................................................................................................ 10\nProvider Directory......................................................................................................................................................... 12\nJuly 2019 New York State Medicaid Update pg. 2\n\nPharmacy\nReminder: Pharmacy Delivery Policy\nPrescription and over-the-counter (OTC) drugs dispensed pursuant to a prescription or fiscal order submitted to\nMedicaid for reimbursement for any portion, may be picked up at the pharmacy provider or may be delivered\nfree of charge to the Medicaid fee-for-service (FFS) or Medicaid Managed Care (MMC) member’s home or\nc", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0003", "char_start": 5250, "char_end": 7250, "pages": [3], "text": "prescription or fiscal order submitted to\nMedicaid for reimbursement for any portion, may be picked up at the pharmacy provider or may be delivered\nfree of charge to the Medicaid fee-for-service (FFS) or Medicaid Managed Care (MMC) member’s home or\ncurrent residence including facilities and shelters.\nDelivery Policy:\n• All shipping and/or delivery costs shall be the responsibility of the provider of the service.\n• The pharmacy is responsible for the delivery of product to the intended recipient.\n• Prior to processing a drug claim, the pharmacy must confirm the drug is needed and that the drug had\nnot been discontinued, changed, or is no longer necessary (e.g., the member had changed pharmacy\nprovider); the confirmation must be maintained in the member’s patient record. Automatic refills are not\npermitted.\n• Prior to delivery, the pharmacy must obtain consent from the member or the individual authorized to\nconsent on the member’s behalf to deliver; consent shall be maintained in the member’s patient record.\n• Only the member, or the individual authorized, may receive the delivery.\n• Pharmacy providers must obtain a signature from the Medicaid member, or the individual authorized to\nconfirm the receipt of drugs; signatures must be retrievable upon audit. Electronic signatures captured at\ndelivery are only permitted if retrievable upon audit.\n• Pharmacies that provide drugs via the mail must obtain and maintain for audit purposes either the\nsignature of the member or authorized individual; and the shipping information including member’s name,\naddress, prescription number, shipped date, and carrier for non-controlled drugs.\n• Pharmacies that provide control prescription drugs via the mail must obtain the signature of the member\nor authorized individual and be shipped by a method that can be tracked.\n• The pharmacy is responsible for drug integrity, and must deliver intact, usable drugs, under the\nappropriate storage conditions.\n• The pharmacy is responsible to replace l", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0004", "char_start": 7000, "char_end": 9000, "pages": [3, 4], "text": "ber\nor authorized individual and be shipped by a method that can be tracked.\n• The pharmacy is responsible for drug integrity, and must deliver intact, usable drugs, under the\nappropriate storage conditions.\n• The pharmacy is responsible to replace lost, stolen, or mis-directed drugs at no additional cost to the\nmember or the Medicaid Program.\n• Pharmacy providers who deliver medication without member or authorized individual consent will be\nrequired to accept the return of the medication, credit Medicaid the claim, and destroy those drugs per\nState Law.\n• All Medicaid claims for drugs not picked up or delivered must be reversed within 60 days or sooner as\nrequired by the mandatory part of New York State’s compliance programs under 18 NYCRR §521.\n• All State counseling laws apply. Additional information can be found at: http://www.op.nysed.gov/\nprof/pharm/pharmcounseling.htm.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 3\n\nPolicy and Billing\nNew York State Medicaid Coverage of CYP2C9 Testing\nfor Siponimod Prescribing\nEffective July 1, 2019 for Medicaid fee-for-service (FFS), and November 1, 2019 for Medicaid Managed\nCare (MMC) Plans (including mainstream MMC plans, HIV Special Needs Plans (HIV SNPs), and Health and\nRecovery Plans (HARPs)), New York State (NYS) Medicaid will begin covering testing of CYP2C9 gene analysis\nto determine eligibility for siponimod drug therapy. Testing of the CYP2C9 gene is reimbursable once in a lifetime\nand should be billed using Current Procedural Terminology (CPT) code “81227”.\nQuestions:\n• Medicaid FFS coverage and policy questions should be directed to the Office of Health Insurance\nPrograms (OHIP), Division of Program Development and Management at (518) 473–2160.\n• Medicaid MMC general coverage questions should be directed to the OHIP, Division of Health Plan\nContracting and Oversight at: covques@health.ny.gov or (518", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0005", "char_start": 8750, "char_end": 10750, "pages": [4, 5], "text": "Insurance\nPrograms (OHIP), Division of Program Development and Management at (518) 473–2160.\n• Medicaid MMC general coverage questions should be directed to the OHIP, Division of Health Plan\nContracting and Oversight at: covques@health.ny.gov or (518) 473–1134.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee's MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nNew York State Medicaid Coverage of Duchenne Muscular Dystrophy\n(DMD) Testing for Exondys 51® Prescribing\nEffective July 1, 2019 for Medicaid fee-for-service (FFS) and November 1, 2019 for Medicaid Managed\nCare (MMC) Plans (including mainstream MMC plans, and HIV Special Needs Plans (HIV SNPs)), New York\nState (NYS) Medicaid will begin covering testing of the DMD gene in individuals who are being considered for\ntreatment with Exondys 51® (eteplirsen). Testing of the DMD gene is reimbursable once in a lifetime and should\nbe billed using Current Procedural Terminology (CPT) code “81161”.\nQuestions:\n• Medicaid FFS coverage and policy questions should be directed to the Office of Health Insurance\nPrograms (OHIP), Division of Program Development and Management at (518) 473–2160.\n• Medicaid MMC general coverage questions should be directed to the OHIP, Division of Health Plan\nContracting and Oversight at: covques@health.ny.gov or (518) 473–1134.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee's MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 4\n\nNew York State Medicaid Expansion of Prognostic\nTests for Breast Cancer Treatment\nThis polic", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0006", "char_start": 10500, "char_end": 12500, "pages": [4, 5], "text": "*************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 4\n\nNew York State Medicaid Expansion of Prognostic\nTests for Breast Cancer Treatment\nThis policy outlines New York State Medicaid coverage of prognostic breast cancer assays as of August\n1, 2019 for Medicaid fee-for-service (FFS), and November 1, 2019 for Medicaid Managed Care (MMC)\nPlans (including mainstream MMC plans, HIV Special Needs Plans (HIV SNPs), and Health and Recovery Plans\n(HARPs)). The prognostic breast cancer assays eligible for reimbursement are Oncotype DX®, EndoPredict®\nand Prosigna®. Coverage of the Oncotype DX® test for Breast Cancer was added in 2015. Oncotype DX®,\nEndoPredict®, and Prosigna® prognostic gene expression tests assist practitioners in making determinations\nregarding the effective and appropriate use of chemotherapy in female or male patients with malignant\nneoplasms of the breast, when all of the following criteria* are met:\n• When the test results will aid the patient and practitioner in making the decision regarding chemotherapy\n(i.e., when chemotherapy is a therapeutic option and is not precluded due to any other factor); and\n• The tumor is estrogen receptor positive (ER+), progesterone receptor positive (PR+), or both; and\n• Human epidermal growth factor receptor 2 (HER2) negative; and\n• Tumor is T1 or T2; and\n• Node-negative or 1-3 positive nodes.\n*NYS Medicaid criteria for Oncotype DX®, EndoPredict® and Prosigna® tests is in accordance with current National Comprehensive\nCancer Network (NCCN) Guidelines. In between policy reviews, providers are encouraged to follow the most recent NCCN guidance.\nFFS Billing\nA copy of the pathology report must accompany the laboratory requisition form. Additional laboratory billing\nguidance and instructions for billing “by report” (BR) codes can be found at the following link:\nhttps://www.emedny.org/ProviderManuals/Laboratory/PDFS/Laboratory", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0007", "char_start": 12250, "char_end": 14250, "pages": [5], "text": "gy report must accompany the laboratory requisition form. Additional laboratory billing\nguidance and instructions for billing “by report” (BR) codes can be found at the following link:\nhttps://www.emedny.org/ProviderManuals/Laboratory/PDFS/Laboratory_Procedure_Codes.pdf.\nReminders:\n• MMC Plan rates cannot exceed the negotiated Medicaid FFS rate.\n• Specimens tested within two weeks of discharge from hospital inpatient status are included in the APR-\nDRG payment to the hospital facility.\n• Lab tests are carved out of the ambulatory surgery Ambulatory Patient Group (APG) payment; as such,\nthe Article 28 facility should not report the procedure code for these tests on their ambulatory surgery\nAPG claim. The laboratory will bill Medicaid FFS and MMC Plans directly.\n• Follow-up genetic counseling should be provided to patients who test positive for a genetic condition.\n• Only one prognostic breast cancer assay per histologically distinct tumor is reimbursable. The criteria in\nthis policy must be met for each assay ordered.\n• If the lab determines that the specimen does not meet the testing criteria outlined in this policy, the\nlaboratory will not report a test result and will not bill the payer or the patient.\n• Patient records must indicate that the individual tested has met the required criteria outlined in this\nguidance.\n• All documentation must be maintained for a minimum of six years for FFS and 10 years for MMC plans.\nQuestions:\n• Medicaid FFS Coverage and policy questions should be directed to the Office of Health Insurance\nPrograms (OHIP), Division of Program Development and Management at (518) 473-2160.\n• Medicaid MMC general coverage questions should be directed to the OHIP, Division of Health Plan\nContracting and Oversight at: covques@health.ny.gov or (518) 473–1134.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee’s MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 3", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0008", "char_start": 14000, "char_end": 16000, "pages": [5, 6], "text": "ersight at: covques@health.ny.gov or (518) 473–1134.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee’s MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 5\n\nBilling Guidance for Reporting Alternate Level of Care\nIt has come to the attention of the New York State (NYS) Department of Health (the Department) that some\nhospitals are billing an inpatient acute level of care status when the patient should have been transferred to\nalternate level of care (ALC) status. This article reiterates ALC billing guidance to NYS Medicaid providers to\nensure that the correct billing procedures are followed regarding ALC days.\nNew York Codes, Rules, and Regulations (NYCRR) Title 10, §86-1.15(h) defines ALC services as: \"those\nservices provided by a hospital to a patient for whom it has been determined that inpatient hospital services are\nnot medically necessary, but that post-hospital extended care services are medically necessary, consistent with\nutilization review standards, and are being provided by the hospital and are not otherwise available.\" Hospitals\nmust properly report occurrence span code “75” with the date span the member was in ALC on the acute care\nclaim. eMedNY Inpatient Billing Guideline §2.3.3 requires that ALC claims be split-billed. Split-billing is defined\nin the Guideline as the \"submission of multiple date range claims that when compiled represent the period from\nAdmit to Discharge.\" Hospitals should not bill for acute levels of care for days when patients are in an ALC\nsetting.\nFor more information regarding inpatient billing please see eMedNY’s New York State UB-04 Billing Guidelines–\nInpatient Hospital manual at: https://www.emedny.org/ProviderManuals/Inpatient/PDFS/Inpatient_Billing_\nGuidelines.pdf", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0009", "char_start": 15750, "char_end": 17750, "pages": [6, 7], "text": "are in an ALC\nsetting.\nFor more information regarding inpatient billing please see eMedNY’s New York State UB-04 Billing Guidelines–\nInpatient Hospital manual at: https://www.emedny.org/ProviderManuals/Inpatient/PDFS/Inpatient_Billing_\nGuidelines.pdf.\nQuestions:\n• Medicaid fee-for-service (FFS) coverage and policy questions should be directed to the Office of Health\nInsurance Programs (OHIP), Division of Program Development and Management at (518) 473–2160.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee's MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nUpdate: Credentialed Alcoholism and Substance Abuse Counselor\n(CASAC) Now Approved for Billing Within an Article 28 Setting for\nDSRIP Project 3.a.i and Integrated Outpatient Services\nThis article supersedes the CASAC article published in the February 2019 Medicaid Update. Due to technical\nissues that recently came to our attention, CASAC providers may continue to use the Office of Alcoholism and\nSubstance Abuse Services (OASAS) unlicensed practitioner ID number “02249145” consistent with OASAS\npolicy after September 1, 2019 for services rendered in the Article 28 setting. Once the technical issue is\nresolved, updated guidance will be provided in a future Medicaid Update publication.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 6\n\nBilling Guidance for Reporting Newborn Birth Weights\nIt has come to the attention of the New York State (NYS) Department of Health that some hospitals are\ninaccurately reporting newborn birth weights on inpatient claims. Providers are reminded that pursuant to the\ninpatient billing procedures for All Patient Refined Diagnostic Related Groups (APR DRGs), docu", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0010", "char_start": 17500, "char_end": 19500, "pages": [7], "text": "Department of Health that some hospitals are\ninaccurately reporting newborn birth weights on inpatient claims. Providers are reminded that pursuant to the\ninpatient billing procedures for All Patient Refined Diagnostic Related Groups (APR DRGs), documented in\neMedNY’s New York State UB-04 Billing Guidelines - Inpatient Hospital manual, claims for newborns must\naccurately contain the newborn's birth weight in grams. The birth weight is reported using Value Code “54” in\nthe Value Information segment. To ensure proper payment when billing Medicaid, fee-for-service (FFS) providers\nshould follow the billing guidelines detailed in eMedNY’s New York State UB-04 Billing Guidelines - Inpatient\nHospital manual §2.3.1.2, Rule 3 – Newborns, which can be found at: https://www.emedny.org/ProviderManuals/\nInpatient/PDFS/Inpatient_Billing_Guidelines.pdf.\nQuestions:\n• Medicaid FFS coverage and policy questions may be directed to the Office of Health Insurance Programs\n(OHIP) Division of Program Development and Management at (518) 473–2160.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee’s MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nBilling Guidance for Reporting Mechanical Ventilation\nIt has recently come to the attention of the New York State (NYS) Department of Health (the Department) that\nsome hospitals may be reporting inappropriate International Classification of Diseases Tenth Revision (ICD-10)\nprocedure codes for mechanical ventilation billed to the NYS Medicaid program. The reporting of inappropriate\nICD-10 procedure codes for mechanical ventilation has resulted in overpayments to hospital facilities.\nMechanical ventilation is the use of a device to inflate and deflate a patient’s lungs to deliver air to a patient\nwhose ability to breathe is diminishe", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0011", "char_start": 19250, "char_end": 21250, "pages": [7], "text": "0 procedure codes for mechanical ventilation has resulted in overpayments to hospital facilities.\nMechanical ventilation is the use of a device to inflate and deflate a patient’s lungs to deliver air to a patient\nwhose ability to breathe is diminished or lost. The ICD-10 procedure codes used for mechanical ventilation have\nspecific “consecutive hour” designations used for the claiming of these services.\nHospital inpatient providers need to make certain the ICD-10 procedure code reported on a claim for mechanical\nventilation represents the actual number of continuous hours the member received mechanical ventilation. A\nclinical assessment that supports the member's diagnosis, the requirements for mechanical ventilation, and the\nactual number of continuous hours the member received mechanical ventilation must be included in the\nmember’s medical record and may be subject to review and audit.\nThe Department has contracted with Island Peer Review Organization (IPRO) to review Medicaid fee-for-service\n(FFS) hospital inpatient claims. During the Utilization Review of inpatient claims, claims for mechanical ventilation\nwill be reviewed to ensure that these services are accurately coded and reflect the services provided to the\nmember.\nQuestions:\n• Medicaid FFS coverage and policy questions should be directed to the Office of Health Insurance\nPrograms (OHIP), Division of Program Development and Management at (518) 473–2160.\n• Medicaid Managed Care (MMC) reimbursement, billing, and/or documentation requirement questions\nshould be directed to the enrollee's MMC plan.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343–9000.\n• Clarification on self-disclosing an overpayment may be obtained by visiting the OMIG website at:\nhttps://omig.ny.gov/self-disclosure/submission-information-and-instructions or by contacting OMIG's\nSelf-Disclosure Unit by email at: selfdisclosures@omig.ny.gov or by phone at: (518) 402-7030.\n****************************************", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0012", "char_start": 21000, "char_end": 23000, "pages": [7, 8], "text": "MIG website at:\nhttps://omig.ny.gov/self-disclosure/submission-information-and-instructions or by contacting OMIG's\nSelf-Disclosure Unit by email at: selfdisclosures@omig.ny.gov or by phone at: (518) 402-7030.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 7\n\nAll Providers\nReminder to Sign-up for Electronic Funds Transfer (EFT) and\nElectronic Remittance Advice (ERA) or Portable Document Format\n(PDF) Remittances\nReminder\nBilling providers who are still receiving paper checks and/or paper remittance statements are required to register\nfor Electronic Funds Transfer (EFT) and either Electronic Remittance Advice (ERA) or Portable Document\nFormat (PDF) remittances. Medicaid began phasing in this requirement beginning in September 2012. The\nadvantages of EFT over paper checks include:\n• no lost checks;\n• no delays caused by misdirected checks;\n• mail travel time is eliminated;\n• funds are transferred securely; and\n• trips to and from the bank to deposit Medicaid paper checks are eliminated.\nRemittances\nProviders have two options for paperless remittances:\n• Option 1: ERA in the form of HIPAA-compliant 835/820 formats\nThis will require software to interpret but has advantages for systematic posting of payments.\n• Option 2: PDF version paper remittances delivered electronically via eMedNY's secure website\nThe PDF remittances have many advantages over paper remittances, such as they:\nwill be immediately available every week on the Monday which the Medicaid check is dated and\nwill not be subject to the two-week hold like a paper check or EFT release;\nwill trigger a notification in the providers eXchange account regarding the remittance availability,\nthus removing the wait time for mail;\ncan be downloaded and stored electronically for easy retrieval;\ncan be word-searched in order to help locate specific claims;\nwill look exactly like the paper remittance; and\ncan be", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0013", "char_start": 22750, "char_end": 24750, "pages": [8, 9], "text": "g the remittance availability,\nthus removing the wait time for mail;\ncan be downloaded and stored electronically for easy retrieval;\ncan be word-searched in order to help locate specific claims;\nwill look exactly like the paper remittance; and\ncan be printed with Adobe Reader® (6.0 release or higher required); available for download free\nof charge.\nBoth the EFT and ERA/PDF remittance applications are available online at: https://www.emedny.org/info/\nProviderEnrollment/allforms.aspx. Questions about either application or the sign-up process can be directed to\nthe eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nReminder: Subscribe to the eMedNY LISTSERV®\nThe eMedNY LISTSERV® email system is a method for dissemination of eMedNY-related information and\nnotifications to providers, vendors, and other Medicaid partners. The eMedNY LISTSERV® is a supplement to\nthe Medicaid Update, the official newsletter of the New York State Medicaid program. The eMedNY LISTSERV®\nenables subscribers to instantly receive:\n• alerts for upcoming changes to claims and other transactions editing;\n• announcements about provider training, seminars, webinars, and special web meetings being offered;\n• provider type specific changes in policy and claim submission requirements; and\n• electronic Provider Assisted Claim Entry System (ePACES) changes and enhancements.\nJuly 2019 New York State Medicaid Update pg. 8\n\nThe LISTSERV® email system runs on an open platform and is available free of charge. There is no limitation to\nthe number of individuals who may subscribe from a practice or organization and no limitation on the number of\ncategories one may subscribe to. Providers are encouraged to subscribe to ensure they receive important\neMedNY communications that may impact their practice and business processes.\nSubscribing to the eMedNY LISTSERV® is quick and easy. Providers can simply visit http://w", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0014", "char_start": 24500, "char_end": 26500, "pages": [9], "text": "bscribe to. Providers are encouraged to subscribe to ensure they receive important\neMedNY communications that may impact their practice and business processes.\nSubscribing to the eMedNY LISTSERV® is quick and easy. Providers can simply visit http://www.emedny.org,\nselect the “eMedNY LISTSERV®” button on the right side of the home page, enter a valid email address then\nselect the categories desired. eMedNY LISTSERV® communications are also archived and available for viewing\nat a later time. Please contact the eMedNY Call Center at (800) 343-9000 with any questions related to the\neMedNY LISTSERV®.\n*******************************************************************************************************************\nProvider Training Schedule and Registration\nProviders who are new to Medicaid billing, have billing questions, or who are interested in learning more about\nthe electronic Provider Assisted Claim Entry System (ePACES) should consider registering for Medicaid training.\neMedNY offers various types of training to providers and their billing staff. Training sessions are available at no\ncost to providers and cover information including claim submission, Medicaid Eligibility Verification, and the\neMedNY website.\nSeminars\nSeminars are a valuable opportunity to meet personally with the CSRA eMedNY Regional Representatives in\nyour area. Seminars are in-person training sessions with groups of providers and billing staff conducted at\nlocations throughout New York State. A schedule of seminars by location can be found on the eMedNY website\nat: http://www.emedny.org/training/index.aspx.\nWebinar Training\nWebinar training opportunities are also available. Webinar training sessions are conducted online and providers\nare able to join the meeting from their site location via a computer and telephone. Once registered, providers\nreceive an email with instructions on how to log in and join the webinar at the appropriate time. No travel is\nnecessary.\nMany webinars offer detailed inst", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0015", "char_start": 26250, "char_end": 28250, "pages": [9, 10], "text": " the meeting from their site location via a computer and telephone. Once registered, providers\nreceive an email with instructions on how to log in and join the webinar at the appropriate time. No travel is\nnecessary.\nMany webinars offer detailed instruction on Medicaid's free web-based program ePACES, the electronic provider\nassisted claim entry system, which allows enrolled providers to submit the following types of transactions:\n• claims;\n• eligibility verifications;\n• claim status requests; and/or\n• prior approval/DVS requests.\nTraining dates, locations, and fast and easy registration information is available on the eMedNY website at:\nhttp://www.emedny.org/training/index.aspx. The website is updated quarterly with new sessions. eMedNY\nRegional Representatives are eager to meet with and provide guidance to providers at upcoming training\nsessions. Providers who are unable to access the internet to register, or who have questions about registration,\nshould contact the eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 9\n\nNew York Medicaid EHR Incentive Program\nDistribution to Eligible Professionals & Eligible Hospitals Since the Start of the Program in 2011*\nNumber of Payments: Distributed Funds:\n39,045 $972,441,858\n*As of 7/8/2019\nThrough the New York (NY) Medicaid Electronic Health Record (EHR) Incentive Program eligible professionals\n(EPs) and eligible hospitals (EHs) in NY who adopt, implement, or upgrade certified EHR technology (CEHRT)\nand subsequently become meaningful users of CEHRT, can qualify for financial incentives. The Centers for\nMedicare and Medicaid Services (CMS) is dedicated to improving interoperability and patient access to health\ninformation. The NY Medicaid EHR Incentive Program is a part of the CMS Promoting Interoperability Program,\nbut will continue to operate under the current name, NY Medicaid", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0016", "char_start": 28000, "char_end": 30000, "pages": [10], "text": "(CMS) is dedicated to improving interoperability and patient access to health\ninformation. The NY Medicaid EHR Incentive Program is a part of the CMS Promoting Interoperability Program,\nbut will continue to operate under the current name, NY Medicaid EHR Incentive Program.\nMEIPASS is Open for Payment Year 2018\nThe Medicaid EHR Incentive Program Administrative Support Service (MEIPASS) opened for Payment Year\n(PY) 2018 Attestations on July 1, 2019. The deadline to attest for PY 2018 is September 30, 2019. To attest for\nPY 2018 in MEIPASS please visit: https://meipass.emedny.org/ehr/login.xhtml.\nGreenway Health LLC Products\nGreenway Health LLC identified that certain EHR products are calculating Promoting Interoperability (Meaningful\nUse) measures incorrectly and they are working to fix these issues. Providers who used any of the impacted\nGreenway products during 2018 should complete the “Greenway Health LLC Identification Form.” This form is\navailable to download in Microsoft Excel format at: https://www.health.ny.gov/health_care/medicaid/redesign/\nehr/repository/docs/greenway_form.xlsx. Completed forms can be submitted as an attachment via email to\nattenstation@health.ny.gov.\nWebinars and Q&A Sessions\nA calendar with the date and times of upcoming webinars, as well as registration information, can be found at:\nhttps://www.health.ny.gov/health_care/medicaid/redesign/ehr/calendar/. Upcoming webinars include Security\nRisk Assessment (SRA), Public Health 2019, and PY 2019 State 3 Attestation Preparation.\nNY Medicaid EHR Incentive Program Tutorial Series\nThe NY Medicaid EHR Incentive Program has produced a series of tutorials to assist providers in preparation of\nthe PY 2018 Meaningful Use Attestation and to aid in the event of a post-payment audit. Registration information\nfor the PY2018 Meaningful Use Attestation Series and the Post-Payment Audit Education Series can be found\nat: https://www.health.ny.gov/health_care/medicaid/redesign/ehr/audit/.\nNew York State (NYS) R", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0017", "char_start": 29750, "char_end": 31750, "pages": [10, 11, 12], "text": "of a post-payment audit. Registration information\nfor the PY2018 Meaningful Use Attestation Series and the Post-Payment Audit Education Series can be found\nat: https://www.health.ny.gov/health_care/medicaid/redesign/ehr/audit/.\nNew York State (NYS) Regional Extension Centers (RECs)\nNYS RECs offer free support to help providers achieve Meaningful Use of CEHRT. Support provided by\nNYS RECs includes but is not limited to: answers to questions regarding the program and requirements;\nassistance on selecting and using CEHRT; and help meeting program objectives. NYS RECs offer free\nassistance for all practices and providers located within New York.\nFor Providers Located:\nInside the 5 boroughs of NYC Outside the 5 boroughs of NYC\nContact: Contact:\nNYC REACH New York eHealth Collaborative (NYeC)\nPhone: 1-347-396-4888 Phone: 1-646-619-6400\nWebsite: https://www.nycreach.org. Website: https://www.nyehealth.org\nEmail: pcip@health.nyc.gov. Email: ep2info@nyehealth.org\nJuly 2019 New York State Medicaid Update pg. 10\n\nQuestions\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at:\n1-877-646-5410 (Option 2) or via email at: hit@health.ny.gov.\nPlease Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey\nThe NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\n*******************************************************************************************************************\nJuly 2019 New York State Medicaid Update pg. 11\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud or abuse complaints/allegations, call 1-877-87FRAUD, (877) 873-7283, or visit\nwww.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at https://www.emedny.org/.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (avail", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0018", "char_start": 31500, "char_end": 33088, "pages": [12], "text": "ov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at https://www.emedny.org/.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nTo sign up for a provider seminar, please enroll online at https://www.emedny.org/training/index.aspx. For\nindividual training requests, call (800) 343-9000.\nBeneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following websites:\nhttp://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog\nhttp://nypep.nysdoh.suny.edu/home\neMedNY\nFor a number of services including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment please visit: https://www.emedny.org/\ninfo/ProviderEnrollment/index.aspx and choose the appropriate link based on provider type.\nMedicaid Electronic Health Record (EHR) Incentive Program\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nJuly 2019 New York State Medicaid Update pg. 12", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0019", "char_start": 32838, "char_end": 33088, "pages": [12], "text": "t the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nJuly 2019 New York State Medicaid Update pg. 12", "chunk_type": "text"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0020::table", "char_start": null, "char_end": null, "pages": [1], "text": "\"\"\r\n\"\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0021::table", "char_start": null, "char_end": null, "pages": [4], "text": "\"\"\r\nNew York State Medicaid Coverage of Duchenne Muscular Dystrophy\r\n(DMD) Testing for Exondys 51® Prescribing\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0022::table", "char_start": null, "char_end": null, "pages": [4], "text": "\"\"\r\nQuestions:\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0023::table", "char_start": null, "char_end": null, "pages": [5], "text": "This policy outlines New York State Medicaid coverage of prognostic breast cancer assays as of August,\r\n\"1, 2019 for Medicaid fee-for-service (FFS), and November 1, 2019 for Medicaid Managed Care (MMC)\",\r\n\"Plans (including mainstream MMC plans, HIV Special Needs Plans (HIV SNPs), and Health and Recovery Plans\",\r\n\"(HARPs)). The prognostic breast cancer assays eligible for reimbursement are Oncotype DX®, EndoPredict®\",\r\n\"and Prosigna®. Coverage of the Oncotype DX® test for Breast Cancer was added in 2015. Oncotype DX®,\",\r\n\"EndoPredict®, and Prosigna® prognostic gene expression tests assist practitioners in making determinations\",\r\nregarding the effective and appropriate use of chemotherapy in female or male patients with malignant,\r\n\"neoplasms of the breast, when all of the following criteria* are met:\",\r\n,\r\n,• When the test results will aid the patient and practitioner in making the decision regarding chemotherapy\r\n,\"(i.e., when chemotherapy is a therapeutic option and is not precluded due to any other factor); and\"\r\n,\"• The tumor is estrogen receptor positive (ER+), progesterone receptor positive (PR+), or both; and\"\r\n,• Human epidermal growth factor receptor 2 (HER2) negative; and\r\n,• Tumor is T1 or T2; and\r\n,• Node-negative or 1-3 positive nodes.\r\n,\r\n\"*NYS Medicaid criteria for Oncotype DX®, EndoPredict® and Prosigna® tests is in accordance with current National Comprehensive\",\r\n\"Cancer Network (NCCN) Guidelines. In between policy reviews, providers are encouraged to follow the most recent NCCN guidance.\",\r\n,\r\nFFS Billing,\r\nA copy of the pathology report must accompany the laboratory requisition form. Additional laboratory billing,\r\nguidance and instructions for billing “by report” (BR) codes can be found at the following link:,\r\nhttps://www.emedny.org/ProviderManuals/Laboratory/PDFS/Laboratory_Procedure_Codes.pdf.,\r\n,\r\nReminders:,\r\n,• MMC Plan rates cannot exceed the negotiated Medicaid FFS rate.\r\n,• Specimens tested within two weeks of discharge from hospital inpatient status are included in the APR-\r\n,DRG payment to the hospital facility.\r\n,\"• Lab tests are carved out of the ambulatory surgery Ambulatory Patient Group (APG) payment; as such,\"\r\n,the Article 28 facility should not report the procedure code for these tests on their ambulatory surgery\r\n,APG claim. The laboratory will bill Medicaid FFS and MMC Plans directly.\r\n,• Follow-up genetic counseling should be provided to patients who test positive for a genetic condition.\r\n,• Only one prognostic breast cancer assay per histologically distinct tumor is reimbursable. The criteria in\r\n,this policy must be met for each assay ordered.\r\n,\"• If the lab determines that the specimen does not meet the testing criteria outlined in this policy, the\"\r\n,laboratory will not report a test result and will not bill the payer or the patient.\r\n,• Patient records must indicate that the individual tested has met the required criteria outlined in this\r\n,guidance.\r\n,• All documentation must be maintained for a minimum of six years for FFS and 10 years for MMC plans.\r\n,\r\nQuestions:,\r\n,• Medicaid FFS Coverage and policy questions should be directed to the Office of Health Insurance\r\n,\"Programs (OHIP), Division of Program Development and Management at (518) 473-2160.\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0024::table", "char_start": null, "char_end": null, "pages": [5], "text": "\"• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\"\r\nenrollee’s MMC plan.\r\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\r\n\"\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0025::table", "char_start": null, "char_end": null, "pages": [10], "text": ",Number of Payments:,,,Distributed Funds:,\r\n\"39,045\",,,\"$972,441,858\",,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0026::table", "char_start": null, "char_end": null, "pages": [10], "text": "The Medicaid EHR Incentive Program Administrative Support Service (MEIPASS) opened for Payment Year\r\n\"(PY) 2018 Attestations on July 1, 2019. The deadline to attest for PY 2018 is September 30, 2019. To attest for\"\r\nPY 2018 in MEIPASS please visit:\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0027::table", "char_start": null, "char_end": null, "pages": [10], "text": "The NY Medicaid EHR Incentive Program has produced a series of tutorials to assist providers in preparation of\r\nthe PY 2018 Meaningful Use Attestation and to aid in the event of a post-payment audit. Registration information\r\nfor the PY2018 Meaningful Use Attestation Series and the Post-Payment Audit Education Series can be found\r\nat:\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0028::table", "char_start": null, "char_end": null, "pages": [10], "text": "For Providers Located:,,,,,\r\n,Inside the 5 boroughs of NYC,,,Outside the 5 boroughs of NYC,\r\n\"Contact:\nNYC REACH\nPhone: 1-347-396-4888\nWebsite: https://www.nycreach.org.\nEmail: pcip@health.nyc.gov.\",,,\"Contact:\nNew York eHealth Collaborative (NYeC)\nPhone: 1-646-619-6400\nWebsite: https://www.nyehealth.org\nEmail: ep2info@nyehealth.org\",,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0029::table", "char_start": null, "char_end": null, "pages": [11], "text": "Questions\r\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at:\r\n1-877-646-5410 (Option 2) or via email at: hit@health.ny.gov.\r\n", "chunk_type": "table"}
{"doc_id": "mu_no08_jul19_pr.pdf", "chunk_id": "mu_no08_jul19_pr.pdf::0030::table", "char_start": null, "char_end": null, "pages": [11], "text": ",Please Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey,\r\n\"The NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\",,\r\n", "chunk_type": "table"}
